EyePoint Pharmaceuticals (NASDAQ:EYPT) reported quarterly losses of $(0.52) per share which met the analyst consensus estimate. This is a 23.81 percent decrease over losses of $(0.42) per share from the same period last year. The company reported quarterly sales of $11.56 million which beat the analyst consensus estimate of $10.87 million by 6.39 percent. This is a 28.31 percent increase over sales of $9.01 million the same period last year.
CS Disco Q4 EPS $(0.18) Beats $(0.31) Estimate, Sales $32.54M Beat $31.46M Estimate
CS Disco (NYSE:LAW) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.31) by 41.94 percent. This is a 80 percent decrease over losses of $(0.10) per share from the same
